Search Through Chemistry Grants in Massachusetts in the U.S.

Who We Are

The Creag Foundation is a private grant making foundation established in 2009 in Woodinville, Washington.

The founders of the Creag Foundation believe that meaningful change can only be achieved through hard work, creativity and passion. They also understand the practical mechanisms that allow charitable organizations to succeed and grow. As a group, Creag Foundation principals are dedicated to helping today’s most innovative programs improve the human condition in a wide variety of ways.

Our Focus

The broad purpose of the Foundation is to support the efforts of nonprofit organizations who are innovators in the field of human services. Our particular focus is on smaller organizations that are starting out or established organizations that are looking for funding to take their organization in a new direction.

What We Fund

/ What We Fund

The Creag Foundation is focused on innovation in the industry. We will consider proposals from 501(c)(3) organizations that are finding new ways to address societal issues facing the nonprofit community. Applicants must have held 501(c)(3) status for one year before submitting. If your organization has held 501(c)(3) status for over a year, and your believe that your organization has a new approach to an existing social problem or is addressing a previously unaddressed social issue, you are welcome to contact us and request that we consider your organization for a funding opportunity.

Background

Draper Richards Kaplan Foundation seeks to dramatically improve the lives of underserved communities across the globe by supporting scalable, innovative, and impact-first solutions that leverage existing systems and stakeholders. Our goal is to find social entrepreneurs with dynamic products or services that have a proven ability to positively impact the lives of underserved people, and nurture those organizations at the early stages by providing capacity, capital, and community.

Our application process is designed to be open and accessible, and we accept applications year round from across our priority geographies and sectors. Borrowing from our venture capital legacy, we find exceptional entrepreneurs and provide them with: 

Capacity

• The core of DRK’s model is deep and extensive operational and technical support for each portfolio organization, both through dedicated hands-on Board service and specialist capacity-building resources for fundraising, board and organizational development, leadership, financial support, and scaling strategy,

Capital

• DRK provides up to $300,000 USD in either unrestricted grant funding or investment capital over a three-year period, and

Community

• DRK convenes our portfolio and alumni annually, facilitating connections and community. 

What We Fund

DRK Foundation funds early-stage social impact organizations solving the world’s biggest social and environmental problems using bold, scalable approaches.

What stage of growth does DRK Foundation typically fund?

Early stage: Organizations who are early stage, which we define as post-pilot and pre-scale. This typically means: 

• Your program, product or service is already being used in the market or in the field, 
• You have early indication that your model is having its intended impact on the beneficiary populations,
• Your organization is relatively young (ideally between two and five years old, although we will consider both younger and older organizations).

Venture funding: In the case of for profits, we typically support Seed to Series A organizations, and never lead rounds; we also generally but not exclusively refrain from participating in financings exceeding a $15M USD post-money valuation.  

Mission

The mission of the Hearst Foundations is to identify and fund outstanding nonprofits to ensure that people of all backgrounds in the United States can build healthy, productive and satisfying lives. Through its grantmaking, the Hearst Foundations support well-established nonprofit organizations that address significant issues within their major areas of focus—culture, education, health and social service—and that primarily serve large demographic and/or geographic constituencies. In each area of funding, the Foundations seek to identify those organizations achieving truly differentiated results relative to other organizations making similar efforts for similar populations. The Foundations also look for evidence of sustainability beyond their support.

Whether providing a scholarship to a deserving student, supporting a rural health clinic or bringing artists into schools so children can see firsthand the beauty of the arts, the Foundations’ focus is consistent: to help those in need, those underserved and those underrepresented in society. Since the Foundations were formed in the 1940s, the scale and capabilities of the grant making have changed, but the mission has not.

Culture Grant

The Hearst Foundations fund cultural institutions that offer meaningful programs in the arts and sciences, prioritizing those that enable engagement by young people and create a lasting and measurable impact. The Foundations also fund select programs nurturing and developing artistic talent. Supported organizations include arts schools, ballets, museums, operas, performing arts centers, symphonies and theaters.

Funding Priorities in Culture

In the recent past, 25% of total funding has been allocated to Culture. Organizations with budgets over $10 million have received 60% of the funding in Culture.

The Hearst Foundations are only able to fund approximately 25% of all grant requests, of which about 80% is directed to prior grantees and about 20% is targeted toward new grantees.

Types of Support

Program, capital and, on a limited basis, general and endowment support

PNC Foundation

Strengthening and enriching the lives of our neighbors in communities where we live and work.

Vision & Mission

For decades, we have provided resources to seed ideas, foster development initiatives and encourage leadership in nonprofit organizations where imagination and determination are at work enhancing people's lives everyday.

The PNC Foundation's priority is to form partnerships with community-based nonprofit organizations in order to enhance educational opportunities, with an emphasis on early childhood education, and to promote the growth of communities through economic development initiatives.

Foundation Grant

The PNC Foundation supports a variety of nonprofit organizations with a special emphasis on those that work to achieve sustainability and touch a diverse population, in particular, those that support early childhood education and/or economic development.

Education

The PNC Foundation supports educational programs for children and youth, particularly early childhood education initiatives that meet the criteria established through PNC Grow Up Great. Specifically, PNC Grow Up Great grants must:

• Support early education initiatives that benefit children from birth to age five; and
• Serve a majority of children (>50%) from low- to moderate-income families; and
• Adhere to all other standard PNC Foundation guidelines, as outlined on the PNC Foundation website, applicant eligibility quiz, as well as the Foundation policies and procedures; and
• Include one or a combination of the following:
  • direct services/programs for children in their classroom or community;
  • professional development/workforce development for early childhood educators;
  • family and/or community engagement in children’s early learning
• Additional considerations:
  • The grant focus should include math, science, reading, vocabulary development, the arts, financial education, or social/emotional development.
  • The grant recipient, or collaborative partner, should have early childhood education as an area of focus. If the organization’s focus is beyond birth to age five, the specific grant must be earmarked for birth to age five.
  • Incorporate opportunities for PNC volunteers in classroom or non-classroom-based activities.

Economic Development

Economic development organizations, including those which enhance the quality of life through neighborhood revitalization, cultural enrichment and human services are given support. Priority is given to community development initiatives that strategically promote the growth of low-and moderate-income communities and/or provide services to these communities.

• Affordable Housing
  • The PNC Foundation understands the critical need for affordable housing for low-and moderate-income individuals.
  • We are committed to providing support to nonprofit organizations that:
    • give counseling and services to help these individuals maintain their housing stock;
    • offer transitional housing units and programs; and/or
    • offer credit counseling assistance to individuals, helping them to prepare for homeownership.
• Community Development
  • Because small businesses are often critical components of community growth and help foster business development, the PNC Foundation provides support to nonprofit organizations that
    • offer technical assistance to, or loan programs for, small businesses located in low-and moderate-income areas or
    • support small businesses that employ low-and moderate-income individuals.
• Community Services
  • Support is given to social services organizations that benefit the health, education, quality of life or provide essential services for low-and moderate-income individuals and families.
  • The PNC Foundation supports job training programs and organizations that provide essential services for their families.
• Arts & Culture
  • Support is given for cultural enrichment programs benefitting the community.
• Revitalization & Stabilization of Low-and Moderate-Income Areas
  • The PNC Foundation supports nonprofit organizations that serve low-and moderate-income neighborhoods by improving living and working conditions.
  • Support is given to organizations that help stabilize communities, eliminate blight and attract and retain businesses and residents to the community.

Philanthropy is our commitment to communities in which we operate and broader society. We focus our resources on a limited number of key projects that can deliver valuable benefits from our contributions and those of our partners. We give priority to innovative, high-quality projects that meet the following criteria:

• promote sustainable development
• offer an opportunity for Roche to use its expertise and logistics capabilities
• involve Roche actively at an early stage with local authorities and established partners
• engage Roche employees in cultural (focus on contemporary arts), educational and social activities
• managed by an accredited charity

Our four focus areas

Humanitarian and Social

We direct the majority of our philanthropic donations to humanitarian and social development projects.

Science and education

We are dedicated to programmes that promote scientific interest and provide educational opportunities for young people around the world.

Community and Environment

We are committed to building stronger communities and responding to natural disasters sustainably.

Arts and Culture

We support groundbreaking contemporary art, cultural projects and activities that explore the parallels between innovation in art and in science. 

Mission

Driven by a philanthropic calling to support marginalized communities throughout the world, the Semnani Family Foundation partners with on-the-ground organizations and leverages its resources in a cost-effective and efficient manner that delivers the maximum benefit.

History

Guided by his grandmother Maliheh’s example and teachings, Khosrow Semnani and his wife Ghazaleh established the Semnani Family Foundation in 1993. The foundation’s first grant was issued through CARE International to an orphanage in Romania that cared for newborns affected by HIV. Over the last few decades, the foundation has continued to build upon its mission to empower the disaffected, partnering with a variety of organizations in different countries who can make the greatest impact.

In addition to its global influence, the Semnani Family Foundation established roots within the state of Utah with the founding of Maliheh Free Clinic in 2005 to provide free healthcare to thousands of uninsured people in the Salt Lake City area.

Where We Work

The Semnani Family Foundation focuses primarily on promoting health, education, and disaster relief for marginalized communities all around the world. Driven by a clear mission to adapt and serve at the global level, we have leveraged our resources to make a meaningful impact in the following countries so far:

• Afghanistan
• Bosnia
• Colombia
• England
• Ethiopia
• Ghana
• Guatemala
• India
• Iran
• Kenya
• Madagascar
• Mali
• Mexico
• Pakistan
• Philippines
• Romania
• Somalia
• South Africa
• Tanzania
• Tonga
• Uganda
• United States
• Yemen

At the heart of the Foundation lies a fervent commitment to human welfare, always prioritizing health and the needs of society’s most vulnerable.

We have strong partnerships with nonprofit organizations across the country that are working to advance economic mobility and social progress in low- and moderate-income communities. Our focus areas include basic needs like food and housing, workforce development and education, and community development. In addition to our philanthropic investments, we also encourage our employees to make a difference by offering robust employee giving and volunteering programs, including the opportunity to direct funds to organizations they support through volunteer efforts, and a matching gifts program that doubles their individual giving to causes they care about. Last year, we invested $350 million in the communities we serve, and employees contributed more than 1 million volunteer hours and directed $65 million through individual giving and matching gifts to support nonprofits.Through our regional U.S. sponsorships, we support the economic, social and cultural life of the places we live and work. We provide an extensive program of arts and sports sponsorships to help maintain vibrant, healthy communities.Sponsorships supporting communitiesBank of America welcomes your sponsorship proposal for opportunities that make our communities a better place to live and work. We are particularly interested in providing support to address needs vital to the health of our communities through a focus on:

• preserving neighborhoods;
• educating the workforce for 21st century jobs;
• addressing critical needs such as hunger and emergency shelter;
• arts and culture;
• the environment; and
• diversity and inclusion programs.

Grants are made at the Foundation’s discretion based on our current funding strategies focused on housing, jobs and hunger. 

Our Mission

The Tony Robbins Foundation is a nonprofit organization created to empower individuals and organizations to make a significant difference in the quality of life of people often forgotten.

We’re dedicated to creating positive changes in the lives of youth, seniors, the hungry, homeless and the imprisoned population, all who need a boost envisioning a happier and deeply satisfying way of life. Our passionate staff, generous donors and caring group of international volunteers provide the vision, inspiration, and resources needed to empower these important members of our society.

Grants

Dedicated to meeting challenges within the global community, creating solutions and taking action, The Tony Robbins Foundation provides monetary donations to various organizations around the world. Funding requests are evaluated on an ongoing basis. We look for organizations that align with our mission to empower individuals and organizations to make a significant difference in the quality of life of those often forgotten.

Ameriprise Financial Grantmaking

At Ameriprise Financial, giving back is deeply rooted in our culture. We’ve initiated positive change in the communities where we live and work for more than 120 years. We believe our community involvement enables us to actively live our values. Through grant making, volunteerism and employee and financial advisor gift matching programs, we support a diverse group of over 6,000 nonprofits across the country.

Focus Areas

Awarding grant dollars to nonprofits is one way we strengthen our communities and help individuals on a path to financial independence. To ensure we're meeting the needs of our communities and making an even greater collective impact, we focus on three key giving areas when awarding grants.

Volunteer engagement is a priority across all focus areas:

The engagement of Ameriprise employees and financial advisors is a critical component of our philanthropy. Whether it’s serving on a nonprofit board, engaging friends, clients and community members in volunteering or providing skills-based support, our relationships with nonprofits go deep. For this reason, we give priority across all focus areas to applications where there is active volunteer engagement of Ameriprise advisors and employees. 

Meeting Basic Needs

At Ameriprise Financial, we help clients achieve financial security and peace of mind. That’s satisfying, meaningful work. We also help the people in our neighborhoods who struggle to meet basic needs such as where their next meal comes from, where they’ll sleep tonight or how they’ll find a higher wage job. We’re here to help them through the three platforms of our Meeting Basic Needs focus area.

Consideration is given to applications addressing the following: 

• Hunger
• Food banks, food shelves and food pantries, daily meal programs or meal services for the homebound
• Hunger-relief programs targeted to meet the special needs of children, ethnic populations or veterans
• Food programs run by nonprofits where hunger is not their sole focus, for example a youth meal program at the YWCA or a backpack program run by a Boys & Girls Club
• Shelter
• Emergency shelter, including youth homelessness
• Transitional housing, permanent supportive housing and efforts to end chronic homelessness
• Housing-first models (programs quickly providing housing and then addressing needed services)
• Achieving and maintaining home ownership, repair and maintenance efforts helping keep seniors, veterans and other populations in their homes 
• Adult Self-Sufficiency: Programs serving adults age 21 and older that help address the following areas:
• Basic hard and soft skills that help adults achieve economic and family stability
• Basic financial and budgeting skills
• Increase employability and wages, including work readiness and job transitions
• Employment of disabled adults

Supporting Community Vitality

We believe communities should be strong, healthy and resilient. We want livable places for all, where neighbors look out for one another, cultural events are well-attended and people pull together in times of crisis and joy. We work to create economic vitality and cultural enrichment through the following areas of focus.

Consideration is given to applications addressing the following: 

• Community Development
• Neighborhood revitalization
• Economic development
• Strengthening and supporting small businesses and nonprofits through technical expertise
• Cultural Enrichment
• Arts education
• Access for underserved populations
• Diverse artists and performances that spark topical community conversations 

Volunteer Driven Causes: Ameriprise employees and financial advisors are outstanding volunteers who serve in teams and also as individuals bringing personal skill-sets to nonprofits. Volunteering is part of the culture at Ameriprise and we are proud to support communities through contributions of both service and financial resources. 

Funding for Volunteer-Driven Causes is determined by current Ameriprise volunteerism. In general, funding is in proportion to the size of the Ameriprise volunteer team supporting a nonprofit. A team may include employees, financial advisors and/or staff or a combination of any Ameriprise volunteers. 

The Foundation is dedicated to providing financial assistance to organizations committed to improving our world. Solutions to the problems of today's world still lie in the values of innovation, practicality, hard work, and compassion.

The Foundation considers applications for grants in the following areas:

• Education
• Social Service
• Health care
• Civic and cultural
• Environmental

The categories above are not intended to limit the interest of the Foundation from considering other worthwhile projects. In general, the Foundation guidelines are broad to give us flexibility in providing grants.

The majority of our grants are made in the U.S. However, like Dr. Scholl, we recognize the need for a global outlook. Non-U.S. grants are given to organizations where directors have knowledge of the grantee.

Our Mission

The purpose of the Ono Initiative is to support scientist Principal Investigators (“PIs”) with creative ideas in selected scientific research fields with the mission of seeking discoveries/solutions and development of high impact science.

Goals

The goals of the Ono Initiative are:

• Supporting Innovation
  • Identify and help develop innovative research proposals and results that could lead to the development of breakthrough treatment solutions for patients.
• Promoting Scientists
  • Support academic research and the career development of promising young and established scientists.
• Building Relationships
  • Build strong relationships within the community in order to lead to transformative research aligned with the Ono Initiative’s goals.

Area of Research

Annually, the Ono Pharma Foundation considers proposals from PIs for research that could ultimately transform human health. Although additional areas of research may be added in future years, the Ono Pharma Foundation will only consider proposals for scientific research addressing Chemical Biology research.

Chemical Biology is defined as research that deals with the interface between chemistry and biology. The criteria for this field are deliberately broad so as not to disqualify potentially innovative and groundbreaking projects.

Selection Criteria

Applications will be assessed, and Awards will be made based upon the following criteria:

• Scientific merit of the research LOI and/or Proposal
• Relevance of proposed research to the mission of the Ono Initiative
  • Significance
  • Innovation
  • Approach
• Technical considerations for the research
  • Applications will be judged on their consideration and understanding of the technology required for completion.
• Qualifications and relevant experience of the PI
• Evidence of a suitable research environment

Funding

All grants awarded by Ono Pharma Foundation have a three year term.

Awards will consist of annual funding of $300,000/year, totaling a maximum of $900,000 for the normal term of a research project. The Ono Pharma Foundation will provide up to an additional 15% ($45,000) per year to be used for indirect costs of the PI’s institution. In total, Ono Pharma Foundation’s three-year research awards provide up to $1,035,000 to researchers and their institutions.

Our Mission

Our mission is to continue and further the philanthropic legacy of Gardner Cowles, Jr. and the Cowles family, which includes promotion of education, social justice, health, and the arts.

The Founder

The Cowles Charitable Trust was first established in 1948 by Gardner “Mike” Cowles, Jr. (1903-1985). Born into the Cowles publishing family of Des Moines, Iowa, Mike was the youngest of Gardner Cowles and Florence Call Cowles’ six children. A newspaper editor and publisher by trade, he was committed to his family’s traditions of responsible, public-spirited, and innovative journalism as well as philanthropy. 

The Cowles Charitable Trust supports the arts, education, the advancement of ethical journalism, medical and climate research.

About the Oligonucleotide Therapeutics Society (OTS)

The idea for the OTS was conceived in 2001 in a small secluded castle in Tuscany, Italy, by an international group of renowned oligonucleotide scientists. The idea of the founders was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities,very much like the impact that antibodies had on human therapeutics over the last decade.

Incorporated in the State of Massachusetts in 2002 and granted 501(c)6 nonprofit status with the United States Internal Revenue Service in 2003, the Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics.

The highly regarded annual OTS meeting draws experts from all over the world for cross-disciplinary exchange spanning expertise in chemistry and delivery, to biology, immunology and clinical medicine. It is the intense scientific exchange between attendees during our annual meetings that sets the stage for groundbreaking new ideas.

Our Mission

The Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics.

Local Delivery Grant

Local Delivery Grants support local, grassroots, and new meetings organized and hosted by OTS members with the objective of sharing knowledge among oligonucleotide therapeutics researchers, cultivating professional development and networking.

Applications are submitted on a rolling basis and are reviewed twice annually.

A variety of different event formats will be supported, including one-day local symposia with invited speakers, local networking events (particularly those geared towards professional development and/or junior scientists), and journal club or seminar series with internal or invited speakers. Creativity is welcomed! Examples of supported events could include:

• Local one-day symposium on oligonucleotide therapeutics or related topics
• Networking event – format could include speakers and/or poster session
• Journal club or seminar series including internal and/or external speakers
• Professional development activities such as workshops on scientific writing, CV development, alternative careers, etc. targeted specifically to researchers in academia or industry
• Women in Science or related events promoting diversity in oligonucleotide research
• Discussion panels on trends in oligonucleotide preclinical research, clinical trials, or other relevant topics

Applications will be funded based on the benefit of the activities to oligonucleotide researchers and in particular, junior scientists.

About UNICO 

For over 100 years, UNICO National has served as a compassionate and unwavering leader of the Italian American community. With a mission to promote Italian American heritage and to serve others, UNICO has benevolently impacted local communities while also serving as an esteemed national voice for Italian Americans. Each year, UNICO provides over $1 million dollars to support charitable, scientific, cultural, educational, and literary projects. As a nonpartisan, nonprofit organization, UNICO celebrates the many significant achievements of Italian Americans in the United States.

Founded upon the principle of “Service Above Self,” the members of our chapters across the country devote their time, energy and resources to serve their local communities. UNICO supports various worthy causes, including Cooley’s Anemia, St. Jude Children’s Research Hospital, Mental Health Wellness, and Cancer Prevention and Research, Food Banks, Shelters, and other Community Needs.

The UNICO Foundation awards numerous scholarships through its national scholarship program.

Louise Torraco Memorial Scholarship for Science

The UNICO Foundation will grant two scholarships, valued at $2,500 each, to students currently pursuing a degree in Physical Sciences including but not limited to Agro-Sciences, Astronomy, Chemistry, Earth Sciences, and Physics; or in the Life Sciences including but not limited to Anatomy, Biochemistry, Biology, Botany, Microbiology and Zoology.

About Arthur C. Cope

Cope, an extraordinarily influential and imaginative organic chemist was born on June 27, 1909, in Dunreith, Indiana. He received a bachelor's degree in chemistry from Butler University in Indianapolis in 1929 and a PhD in 1932 from the University of Wisconsin–Madison. His research continued at Harvard University in 1933 as a National Research Council Fellow. In 1934, he joined the faculty of Bryn Mawr College. There, his research included the first syntheses of several barbiturates, including delvinyl sodium. At Bryn Mawr, Cope also developed a reaction involving the thermal rearrangement of an allyl group which eventually became known as the Cope rearrangement.

In 1941, Cope moved to Columbia University where he worked on projects associated with the war effect including chemical warfare agents, antimalarial drugs, and treatments for mustard gas poisoning. In 1945, he moved to the Massachusetts Institute of Technology to become the head of the Department of Chemistry.

Purpose

To recognize individuals for their outstanding achievements in the field of organic chemistry. This two-year postdoctoral fellowship will provide intellectual and academic freedom to early-career postdoctoral researchers. Arthur C. Cope Postdoctoral Fellows will develop bold and creative new research directions in organic chemistry that can contribute to a sustainable world.

Description

The Arthur C. Cope Postdoctoral Fellowship (CPF) of the American Chemical Society (ACS) is a two-year postdoctoral fellowship awarded yearly to Ph.D. candidates or postdoctoral researchers within their first two years of pursuing postdoctoral research in organic chemistry.

The Arthur C. Cope Postdoctoral Fellowship currently provides $85,000 per year for two years of research at a nonprofit institution in the U.S. Arthur C. Cope Postdoctoral Fellows are expected to participate in ACS meetings, mentoring, and other career development activities.

Candidates are nominated by their research advisor or academic mentor (including, but not limited to, their Ph.D. advisor, postdoctoral advisor, or other research mentors). They are evaluated on their outstanding contributions to organic chemistry and their potential to contribute significantly to research, teaching, and innovations in organic chemistry. Applicants must be nominated to be considered for the CPF. 

The Lawrence Foundation is a private family foundation focused on making grants to support environmental, human services and other causes.

The Lawrence Foundation was established in mid-2000. We make both program and operating grants and do not have any geographical restrictions on our grants. Nonprofit organizations that qualify for public charity status under section 501(c)(3) of the Internal Revenue Code or other similar organizations are eligible for grants from The Lawrence Foundation.  

Grant Amount and Types

Grants typically range between $5,000 - $10,000. In some limited cases we may make larger grants, but that is typically after we have gotten to know your organization over a period of time. We also generally don’t make multi-year grants, although we may fund the same organization on a year by year basis over a period of years.

General operating or program/project grant requests within our areas of interests are accepted. In general, regardless of whether a grant request is for general operating or program/project expenses, all of our grants will be issued as unrestricted grants.

About the Oligonucleotide Therapeutics Society (OTS)

The idea for the OTS was conceived in 2001 in a small secluded castle in Tuscany, Italy, by an international group of renowned oligonucleotide scientists. The idea of the founders was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities,very much like the impact that antibodies had on human therapeutics over the last decade.

Incorporated in the State of Massachusetts in 2002 and granted 501(c)6 nonprofit status with the United States Internal Revenue Service in 2003, the Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics.

The highly regarded annual OTS meeting draws experts from all over the world for cross-disciplinary exchange spanning expertise in chemistry and delivery, to biology, immunology and clinical medicine. It is the intense scientific exchange between attendees during our annual meetings that sets the stage for groundbreaking new ideas.

Our Mission

The Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics.

OTS Lifetime Achievement Award

The OTS Lifetime Achievement Award recognizes an individual who has demonstrated a lasting commitment to the field of oligonucleotide therapeutics through outstanding contributions to education, research, and therapeutic application and are an outstanding example to young or new members of the field. Such individuals may have made this contribution through one, or many, of the following descriptions:

• An individual who has made a significant scientific contribution to the field of oligonucleotide medicine, over decades, by means of multiple high impact publications, leadership in the oligonucleotide community, and mentorship to trainees
• An individual who has made an exceptional scientific contribution to the field of oligonucleotide medicine through the publication of one or more revolutionary papers which have made an immediate and significant contribution to the field of oligonucleotide medicine
• An individual who has played a critical role, over decades, guiding decisions at companies and/or in academia and who might not be identified with any one scientific discovery
• An individual who has played a critical role, over decades, in the leadership and/or mentorship or a prolific group of scientists/trainees

Recipient receives:

• $2,500 USD award
• Complimentary registration to the OTS Annual Meeting
• Formal presentation of the award at the OTS Annual Meeting
• Keynote speaking slot at the OTS Annual Meeting

Supporting Biomedical Innovation And Discovery By Early-career Investigators

For over 30 years, the Smith Family Foundation has been supporting groundbreaking medical research through the Smith Family Awards Program for Excellence in Biomedical Research. Its mission is to launch the careers of newly independent biomedical researchers with the ultimate goal of achieving medical breakthroughs. Applications focus on all fields of basic biomedical science and may also be submitted by investigators in physics, chemistry and engineering. Since 1992, the Program has funded 202 scientists for a total investment of $46.1 million.

Three year awards in the amount of $400,000 (inclusive of 5% overhead per year) target new faculty who are within three and a half years of their first independent appointment by the start of funding on April 1st. Applicants must be full-time faculty at nonprofit academic, medical or research institutions in Massachusetts, at Brown University or at Yale University. Further details regarding the eligibility requirements may be found in the “Application Guidelines” document.

In order to ensure that the strongest research candidates from eligible institutions are able to apply, the Smith Family Foundation is a two-stage application process in which the institutional nomination process is eliminated, and any eligible candidate is invited to submit an initial proposal. Applicant eligibility must be verified by the relevant department Chair and the institution’s Office of Sponsored Research or the initial proposal will not be considered. There is no limit on the number of applicants from a given institution. The Scientific Review Committee will select a subset of initial applicants to invite to submit full proposals.

Program Overview and Statement of Purpose

The Smith Family Foundation is committed to effecting permanent positive change in the lives of the residents of Greater Boston, particularly individuals and families in economically disadvantaged communities. In the area of health, the Foundation supports the advancement of biomedical research and the expansion of access to high-quality health care at safety net institutions serving low-income individuals and communities of Greater Boston.

The Smith Family Awards Program for Excellence in Biomedical Research was created in 1991 to launch the careers of newly independent biomedical researchers with the ultimate goal of achieving medical breakthroughs. Since 1992, the Program has funded 202 outstanding scientists and has provided $46.1 million in research support. 

The Smith Family Awards Program for Excellence in Biomedical Research is managed by Health Resources in Action (HRiA). HRiA is a non-profit organization that partners with individuals, organizations, and communities to transform the practices, policies, and systems that improve health and advance equity.

Research Focus

The three-year Award supports newly independent faculty engaged in basic or translational biomedical research. Investigators in the physical sciences (physics, chemistry, and engineering) whose projects focus on biomedical science are also encouraged to apply. While basic research projects involving human subjects, data, and samples are eligible, clinical trials research is beyond the scope of this program.

We invite proposals from starting faculty members who study a wide range of problems in diverse biological systems. For example, we have supported research as diverse as regulated translation in synapse formation, bacterial regulators of immunity, kinetochore function in centromere cohesion, neural codes for perception, and DNA damage pathways in tumors. We recognize that very basic biology discovered in systems ranging from bacteria to plants to human tumors can impact fields as distant as neural pathfinding and immune function. We welcome proposals that range from fundamental biology to translational research. Our review committees have traditionally been composed of researchers from diverse disciplines including bacterial and eukaryotic geneticists, immunologists, neurobiologists, developmental biologists, cancer biologists, and transcriptional regulation experts, who can assess a wide range of biological proposals.

In recognition of the importance of research collaboration within the scientific community, collaboration is an additional, but not required, positive ancillary factor. These projects may involve researchers within and/or outside the applicant’s institution.

About the Oligonucleotide Therapeutics Society (OTS)

The idea for the OTS was conceived in 2001 in a small secluded castle in Tuscany, Italy, by an international group of renowned oligonucleotide scientists. The idea of the founders was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities,very much like the impact that antibodies had on human therapeutics over the last decade.

Incorporated in the State of Massachusetts in 2002 and granted 501(c)6 nonprofit status with the United States Internal Revenue Service in 2003, the Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics.

The highly regarded annual OTS meeting draws experts from all over the world for cross-disciplinary exchange spanning expertise in chemistry and delivery, to biology, immunology and clinical medicine. It is the intense scientific exchange between attendees during our annual meetings that sets the stage for groundbreaking new ideas.

Mary Ann Liebert, Inc. publishers Young Investigator Award

The Mary Ann Liebert publishers, Inc. Young Investigator Award recognizes the outstanding achievements and contributions by a professional scientist in the field of oligonucleotide therapeutics who has received his or her doctoral degree within the previous fifteen years.

Recipient receives:

• $2,000 USD award
• Complimentary registration to the OTS Annual Meeting
• Formal presentation of the award at the OTS Annual Meeting
• Short talk speaking slot at the OTS Annual Meeting

About the Oligonucleotide Therapeutics Society (OTS)

The idea for the OTS was conceived in 2001 in a small secluded castle in Tuscany, Italy, by an international group of renowned oligonucleotide scientists. The idea of the founders was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities, very much like the impact that antibodies had on human therapeutics over the last decade.

Incorporated in the State of Massachusetts in 2002 and granted 501(c)6 nonprofit status with the United States Internal Revenue Service in 2003, the Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics.

The highly regarded annual OTS meeting draws experts from all over the world for cross-disciplinary exchange spanning expertise in chemistry and delivery, to biology, immunology and clinical medicine. It is the intense scientific exchange between attendees during our annual meetings that sets the stage for groundbreaking new ideas.

Poster Awards

The Oligonucleotide Therapeutics Society grants Poster Awards to outstanding students and post docs presenting posters at the OTS Annual Meeting. Posters are judged during the meeting and winners are chosen based on exceptional and promising science as well as presentation of the data.

Recipients receive:

• A $250 USD cash or gift card award
• Certificate and ribbon to display on poster

Community Partnership Award

The Mutual of America Foundation Community Partnership Award recognizes outstanding nonprofit organizations in the United States that have shown exemplary leadership by facilitating partnerships with public, private or social sector leaders who are working together as equal partners, not as donors and recipients, to build a cohesive community that serves as a model for collaborating with others for the greater good.

Each year, the Mutual of America Foundation sponsors a national competition in which hundreds of organizations demonstrate the value of their partnership to the communities they serve, their ability to be replicated by others and their capacity to stimulate new approaches to addressing significant social issues.

Six organizations are selected by an independent committee to receive the Community Partnership Award.

• The Thomas J. Moran Award is given to the national award-winning program and includes $100,000 and a documentary video about the program.
• The Frances R. Hesselbein Award is given to a partnership that is addressing social challenges in more than one community, or which demonstrates the potential to be replicated in other communities. This recipient receives $75,000.
• Four other organizations are named Honorable Mention recipients for their programs, and each receives $50,000.

Since its inception in 1996, the Community Partnership Award has recognized 262 partnerships from cities and towns across America. Like so many of our clients working in the nonprofit community, Mutual of America is dedicated to having a direct, positive impact on society.

About the Oligonucleotide Therapeutics Society (OTS)

The idea for the OTS was conceived in 2001 in a small secluded castle in Tuscany, Italy, by an international group of renowned oligonucleotide scientists. The idea of the founders was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities,very much like the impact that antibodies had on human therapeutics over the last decade.

Incorporated in the State of Massachusetts in 2002 and granted 501(c)6 nonprofit status with the United States Internal Revenue Service in 2003, the Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics.

The highly regarded annual OTS meeting draws experts from all over the world for cross-disciplinary exchange spanning expertise in chemistry and delivery, to biology, immunology and clinical medicine. It is the intense scientific exchange between attendees during our annual meetings that sets the stage for groundbreaking new ideas.

Our Mission

The Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics.

OTS Awards for Science Outreach and Patient Advocacy 

One of OTS’s core values is to provide trustworthy information to the public, to provide access to experts, and to amplify the voices of patients. In 2022, the society established two awards to recognize outstanding contributions by individuals who share their scientific knowledge with the public, or who promote patient advocacy. The OTS Awards for Science Outreach and Patient Advocacy aim to recognize the efforts of researchers and individuals who excel in these areas. OTS welcomes nominations for both of these awards annually.

Recipients receive:

• $500 USD award & certificate
• Complimentary registration to the current year’s OTS Annual Meeting
• Featured profile on OTS social media
• Option to present a webinar

About the Oligonucleotide Therapeutics Society (OTS)

The idea for the OTS was conceived in 2001 in a small secluded castle in Tuscany, Italy, by an international group of renowned oligonucleotide scientists. The idea of the founders was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities, very much like the impact that antibodies had on human therapeutics over the last decade.

Incorporated in the State of Massachusetts in 2002 and granted 501(c)6 nonprofit status with the United States Internal Revenue Service in 2003, the Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics.

The highly regarded annual OTS meeting draws experts from all over the world for cross-disciplinary exchange spanning expertise in chemistry and delivery, to biology, immunology and clinical medicine. It is the intense scientific exchange between attendees during our annual meetings that sets the stage for groundbreaking new ideas.

Paper of the Year Awards

Paper of the Year Awards are designed to honor the most impactful papers in the field of oligonucleotide therapeutics.

There are two categories for Paper of the Year Awards reflecting the scope of excellent research being done in the field of oligonucleotide therapeutics:

• Basic Research – Paper must be on a Basic Research (pre-clinical) topic relevant to oligonucleotide therapeutics
• Late Discovery – Paper must be on a Late Discovery (large pre-clinical models and clinical studies) topic relevant to oligonucleotide therapeutics

Recipients receive:

• $1,000 USD award
• Presentation of an award certificate at the OTS Annual Meeting

The Rowland Institute at Harvard seeks outstanding early-career experimentalists in all fields of science and engineering. The Rowland Fellowship provides an opportunity to establish an independent program in the rich intellectual environment of Cambridge, Massachusetts.

Edwin Land founded the Rowland Institute of Science in 1980 to foster high-risk, creative research. In 2002, we became the Rowland Institute at Harvard when we joined the University with the mission of advancing the early careers of experimental scientists and engineers. In 2024 we moved from our original building to main campus to be closer to collaborators and university resources. In our founder’s tradition, we are particularly interested in supporting scholars who have the potential to establish a ground-breaking research program in a field that bridges traditional disciplinary boundaries. Previous Rowland Fellows have gone on to extremely successful careers, mostly in academia, but also in industry and as founders of startup companies. 

The benefits of a Rowland Fellowship include:

• Fellows will have full principal investigator rights and will establish their labs in an interdisciplinary and interactive environment, in the rich intellectual environment of Cambridge, Massachusetts.
• Fellows will be provided with dedicated laboratory space, and ancillary spaces as needed (e.g. cell culture, magnet rooms etc); generous start-up funding for capital equipment, depending on the Fellow’s research program; a yearly budget starting at $225,000 for general operations (lab supplies, travel, etc.) and the hiring of personnel (postdoctoral fellows, postbacs, undergraduates); and, a salary that begins at $89,999 per year with full Harvard benefits.
• Fellows will have the opportunity to teach undergraduates for at least one semester during their Fellowship, to enable contact with students (ideally in an active research setting, rather than in a classroom), both to help Fellows recruit talented students to their labs and to provide teaching experience that will help them in any career they choose.
• Staff scientists and engineers are available to work directly with Rowland Fellows to design and fabricate new experimental set-ups. Shared research equipment is available at facilities within the Institute and also throughout Harvard University (e.g. the Center for Nanoscale Systems, and the Bauer Life Science Core Facility). 
• Fellows will receive mentoring to develop a productive lab culture, support for scientific writing and budgeting, alongside ongoing support for career development throughout the Fellowship period, including leadership training and access to Harvard’s Core for Mentorship Excellence.

The Fellowship lasts up to five years, with a flexible start date; incoming 2026 Rowland Fellows will have start dates September-December 2026.

Gupta Family Foundation is a private, nonprofit foundation headquartered in Herndon, Virginia, USA. Our mission is to support organizations that provide focused intervention in the lives of people who have been disadvantaged in some way to help them become self-reliant. We take a very broad view of “disadvantage” to include anything that holds a person back from realizing their potential, such as poverty, physical or mental disability, social alienation, etc. The foundation also supports relief agencies that serve people affected by emergencies such as natural disasters.

The foundation evaluates and awards annual and multi-year grants ranging from $5,000 to over $250,000 (USD). Our focus is on funding smaller organizations all around the world that are led by individuals with a deep personal commitment to their missions. 

Our selection criteria include:

• Mission alignment
• The organization is run by the founder or, if not, by a successor who embodies the original inspiration, passion and commitment of the founder.
• At least 90% of grant monies reaches the intended beneficiaries.
• The organization is non-sectarian, i.e.,
  • It does not, directly or indirectly, support or condone the proselytization of any religion,
  • It is not supported by or affiliated to a religious organization.

The Dudley T. Dougherty Foundation Vision

The Dudley T. Dougherty Foundation, "A Foundation for All", was established in 2002. It was begun in order to give a clear voice for those who wish to be a part of the many, worthy, forces for change in our world.

We are a foundation whose purpose is to look ahead towards the future, giving the past its due by remembering where we came from, and how much we can all accomplish together. We aim to make the critical difference on our planet by recognizing and having respect for our ever changing world. We respect all Life, the Environment, and all People, no matter who they are.

Georgia-Pacific Foundation

Established in 1958, the Georgia-Pacific Foundation sets aside resources to improve life in the communities where we operate. We’ve worked with thousands of outstanding community-based programs, service projects and disaster relief efforts, focusing our investment in four areas we believe make the most impact:

• education
• entrepreneurship
• enrichment of community
• environment

Investment Priorities

• Aligns with GP’s mission and values
• Aligns with GP’s Four Focus Areas of giving: Education, Environment, Enrichment of Community and Entrepreneurship
• Serves communities where GP has manufacturing facilities
• Creates value by contributing to and positively impacting long term well-being and sustainability of GP communities